Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF449 Inhibitors

The chemical class known as ZNF449 inhibitors encompasses a diverse group of compounds that interact with cellular processes to modulate the function of the zinc finger protein ZNF449, a transcription factor that binds to DNA and regulates gene expression. These inhibitors work by targeting the various mechanisms that ZNF449 relies on to exert its regulatory role within the cell. For instance, some compounds in this class are designed to alter epigenetic marks, such as DNA methylation and histone acetylation, which can change the accessibility of ZNF449 to chromatin and consequently its ability to bind to DNA. By affecting the chromatin structure, these inhibitors can modulate the interaction of ZNF449 with its target genes, thereby influencing its regulatory function. Other members of this class can interfere with the post-translational modifications of ZNF449 or its co-regulators, such as phosphorylation, which is crucial for the proper localization and function of the protein within the cell.

In addition to epigenetic and post-translational modifications, ZNF449 inhibitors can also affect signaling pathways that are important for ZNF449's activity. Compounds that inhibit specific kinases or phosphatases can alter the phosphorylation state of ZNF449, which can modulate its activity. Furthermore, inhibitors that target signaling molecules can disrupt the downstream effects that these pathways have on ZNF449's function, including changes in protein-protein interactions and alterations in the expression of genes that ZNF449 normally controls. The chemical diversity of ZNF449 inhibitors is reflective of the complex network of cellular interactions and processes that ZNF449 is involved in. By precisely targeting these interactions, ZNF449 inhibitors can effectively modulate the function of this transcription factor and the vast array of genetic pathways it influences. Overall, the development of ZNF449 inhibitors is guided by a detailed understanding of the molecular mechanisms governing ZNF449's role within the cell, providing a framework for the fine-tuning of its activity through chemical intervention.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could inhibit DNA methyltransferases, leading to the demethylation of gene promoters. If ZNF449 requires methylated regions to properly bind DNA, the demethylation could possibly inhibit ZNF449's ability to regulate gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Similar to Trichostatin A, SAHA would increase histone acetylation, potentially affecting ZNF449's interaction with chromatin. This could alter the transcriptional regulation of genes that ZNF449 controls and possibly inhibit ZNF449.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

This aldehyde dehydrogenase inhibitor could modify the cellular redox state, which might affect the stability and function of ZNF449, particularly if ZNF449's activity is redox-sensitive and could possibly inhibit it.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

By inhibiting MEK, part of the MAPK/ERK pathway, PD98059 could prevent the phosphorylation of ZNF449 or its co-factors, which may be necessary for its proper function or localization within the cell and could possibly inhibit ZNF449.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a PI3K inhibitor, LY294002 could disrupt Akt signaling, potentially affecting processes that control the transcriptional activity of ZNF449, such as its phosphorylation state or interaction with other proteins, and could possibly inhibit it.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Inhibiting the Hedgehog signaling pathway with Cyclopamine could alter the transcription of genes that are co-regulated by ZNF449, affecting its role in gene expression networks and could possibly inhibit ZNF449.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, Decitabine could inhibit DNA methyltransferases, leading to reduced DNA methylation and potentially impairing ZNF449's DNA-binding ability and could possibly inhibit its subsequent gene regulation.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

This CDK4/6 inhibitor could impact cell cycle-related gene expression. If ZNF449 is involved in the regulation of these genes, inhibiting their expression with Palbociclib could possibly inhibit ZNF449's function.

Kenpaullone

142273-20-9sc-200643
sc-200643A
sc-200643B
sc-200643C
1 mg
5 mg
10 mg
25 mg
$61.00
$153.00
$231.00
$505.00
1
(1)

By inhibiting GSK-3, Kenpaullone could affect Wnt signaling and other cellular processes. If ZNF449 plays a role in these pathways, then GSK-3 inhibition could possibly alter ZNF449's activity or stability.